drugset / Trial / NCT00058968

A Study for the Treatment of Painful Diabetic Neuropathy

NCT00058968

Phase 3 Completed 660 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.

Timeline

Start
2002-10
Primary completion
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg